APOLLO: A phase I study of adaptive memory natural killer (NK) cells in recurrent ovarian cancer.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Minnesota, Fate Therapeutics (United States)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3029919824
